先端分野の市場情報を提供する株式会社グローバルインフォメーション（神奈川県川崎市、代表取締役社長：小野 悟）は、2012年1月31日～2月1日 米国、サンディエゴにて開催されます、Cambridge Healthtech Institute主催 国際学会「Biomarker Assay Development （バイオ ...

先端分野の市場情報を提供する株式会社グローバルインフォメーション（神奈川県川崎市、代表取締役 社長：小野 悟）は、2011年1月31～2月2日 米国、サンディエゴにて開催されます、Cambridge Healthtech Institute主催 国際会議・展示会「Biomarker Assay Development ...

We spoke with Scott Jones, PhD, SVP & CSO at BioBridge Global (BBG) to understand the challenges of product-specific potency ...

Perceptive Discovery, the preclinical and translational services division of Perceptive, today announced a $15M series of ...

Assays are investigative procedures that qualitatively assess a compound or examine a compound’s effects on identified molecular, cellular, or biochemical targets. The first steps in drug development ...

Market Growth Driven by Rising Chronic Disease Prevalence, Increasing Geriatric Population, High Burden of Infectious Diseases, and Growing Focus on Point-of-Care IVD Assays REDDING, Calif., June 30, ...

REDDING, Calif., Oct. 24, 2024 /PRNewswire/ -- According to a new market research report, 'IVD Assay Development Market Size, Share, Forecast, & Trends Analysis by Offering (Assay Development, ...

VENLO, Netherlands, June 18, 2025--(BUSINESS WIRE)--QIAGEN (NYSE: QGEN; Frankfurt Prime Standard: QIA) and GENCURIX, Inc. (KOSDAQ: 229000) today announced a new partnership to develop oncology assays ...

The COVID-19 pandemic and geopolitical conflict in Eastern Europe have done irreparable damage to the underpinnings of the clinical diagnostic industry. These events significantly impacted the supply ...